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Serum Creatinine as Marker of Kidney Function in South
Asians: A Study of Reduced GFR in Adults in Pakistan
Tazeen H. Jafar,*†‡ Christopher H. Schmid,§ and Andrew S. Levey‡
*Section of Nephrology, Department of Medicine, and †Clinical Epidemiology Unit, Department of Community Health
Sciences, The Aga Khan University, Karachi, Pakistan; and ‡Division of Nephrology, Department of Medicine, and
§
Division of Clinical Care Research, Department of Medicine, Tufts-New England Medical Center, Tufts University
Medical School, Boston, Massachusetts
Migrant populations of South Asian origin have a higher risk for chronic kidney disease than the native whites. Several
formulas have been developed to estimate kidney function from serum creatinine concentration. However, none of these has
been validated in the South Asian population, which generally has different muscle mass composition than whites. A
population-based cross-sectional study was performed on 262 individuals who were aged >40 yr in Karachi, Pakistan.
Reduced GFR was defined as creatinine clearance (Ccr) measured in 24-h urine collection of <60 ml/min per 1.73 m2.
Creatinine excretion was compared with age- and gender-matched white individuals by comparison of observed versus
expected results on the basis of a formula using t test. The agreement among Cockcroft Gault (CG) Ccr and Modification of
Diet in Renal Disease (MDRD) Study GFR equations was assessed by regression analyses, and the degree of accuracy of
estimated versus measured GFR was determined. Mean (95% confidence interval) creatinine excretion was 1.7 (1.0 to 2.4) mg/kg
per d lower than expected for age- and gender-matched white individuals (P < 0.001). The coefficient of determination for
measured Ccr on the logarithmic scale was 66.7 and 55.6% for the CG and MDRD Study equations, respectively. The
proportion of estimates within 20, 30, and 50% of measured Ccr values was 47.7 versus 32.8% (P < 0.001), 64.9 versus 49.6% (P <
0.001), and 79.4 versus 72.9 (P ⴝ 0.07) for CG versus MDRD Study equations, respectively. Lower mean creatinine excretion in
these individuals may explain, in part, suboptimal agreement between estimated versus measured GFR. Inclusion of terms for
ethnic and racial groups other than white and black might improve the performance of GFR estimating equations.
J Am Soc Nephrol 16: 1413–1419, 2005. doi: 10.1681/ASN.2004121100

A

lmost one quarter of the world’s population resides in
South Asia (India, Pakistan, Bangladesh, Sri Lanka,
and Nepal). Evidence from the Western countries is
emerging that migrant populations of South Asian origin have
a higher risk for chronic kidney disease (CKD) than the native
whites (1–3). Although no reliable data are available on the
incidence and prevalence of CKD in South Asia, the burden of
its risk factors, including hypertension and diabetes, in this
population is one of the highest in the world (4,5). Therefore,
the burden of CKD is expected to be equally high.
Untreated CKD may progress to kidney failure and is associated with increased cardiovascular morbidity and mortality
and all-cause mortality. Evidence suggests that some of these
adverse outcomes can be prevented or delayed by early detection and treatment of CKD (6 –10).
The GFR is traditionally considered the best overall index of
kidney function in health and disease (11). Early detection of
CKD requires identification of individuals with reduced GFR.
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A GFR level of ⬍60 ml/min per 1.73 m2 represents loss of half
or more of the adult level of normal kidney function and is
classified as CKD (11,12). Traditionally, GFR has been estimated by measurement of serum creatinine and creatinine excretion in a 24-h urine sample and computation of creatinine
clearance (Ccr). Collection of urine for determining Ccr is difficult in clinical practice; thus, clinicians generally rely on serum creatinine alone as an index of GFR. Unfortunately, serum
creatinine is affected by factors other than GFR, in particular
muscle mass and meat intake, which differ in the South Asian
populations compared with the white and black populations in
which these factors have been studied. Several formulas have
been developed to estimate GFR from serum creatinine concentration, age, gender, and body size (13–15). The drug-dosing
intervals are determined on the basis of one of these formulas,
the Cockcroft-Gault (CG) prediction equation. However, none
of the currently available estimating equations has been validated in the South Asian population. Similarly, the utility of
threshold values for serum creatinine to detect reduced GFR
has not been examined in the South Asian population.
We conducted this study to determine the prevalence of
reduced GFR, defined as a Ccr measured in 24-h urine collection of ⬍60 ml/min per 1.73 m2 in adults aged 40 yr or older in
Karachi, Pakistan. We compared observed creatinine excretion
with expected values on the basis of a predominantly white
ISSN: 1046-6673/1605-1413
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population. We compared the performance of the CG and
Modification of Diet in Renal Disease (MDRD) Study equations
for measured Ccr in a South Asian population. Finally, we also
sought to assess the sensitivity and specificity expressed by
receiver operating characteristic (ROC) curves for serum creatinine concentration, estimates of GFR from CG and MDRD
Study equations for the diagnosis of reduced GFR.

Materials and Methods
Sample Size
On the basis of the assumption that at least 30% of individuals would
have Ccr of ⬍60 ml/min, approximately 330 individuals were needed
to detect this prevalence with error bounds of 2%.

Sampling Details
The sample was drawn using two-stage sampling from one of the
communities (clusters of households) in the metropolitan city of Karachi, after obtaining approval from the Ethical Review Committee at the
Aga Khan University. The site was chosen as this study was piggybacked to an ongoing study of prevalence of hypertension in this
community of individuals belonging to the Pashtun ethnic subgroup
(4). A total of 5920 residential structures were numbered and mapped
in the study cluster. Twenty-five percent (1480) of these structures
(every fourth) were systematically selected. Complete listing of household members was done in 1426 households. The total number of
individuals who resided in these households was 11,765, 1765 of whom
were aged 40 yr or older and constituted our sampling frame. A target
sample of 332 individuals, stratified by gender, was randomly selected
for the study, and informed consent was sought. A total of 295 individuals consented to participate.
Trained community health workers paid home visits to the selected
individuals to invite and motivate them for their participation in the
study and to obtain informed consent. To improve participation, refreshment was given after laboratory sampling, and the results of the
laboratory tests were delivered to all participants with advice.
Instructions on 24-h collection of urine were given, and bottles for the
same were provided. All individuals were evaluated at the community
clinic in their areas by trained nurses. The evaluation included the
following: (1) administration of questionnaire that details smoking
status, food frequency questionnaire, and other lifestyle factors and
Rose questionnaire for angina; (2) assessment of BP with calibrated
automated device (Omron HEM-737 Blood Pressure Monitor) in sitting
position after 5 min of rest; (3) anthropometry (height, weight); (4)
laboratory tests including fasting blood glucose (Synchron Cx-7/Delta,
Beckman, Ramsey, MN) and serum and 24-h urine creatinine (Jaffe
method, Beckman DU); and (5) an ECG. All measurements were performed to a standard protocol that conformed to the international
standards for definitions and measurements. The study was conducted
over 1 yr (2001 to 2002).
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computed using the formula BSA ⫽ height0.725 (cm) ⫻ body weight0.425
(kg) ⫻ 0.007184.
Estimated Ccr using the CG equation (Ccr, ml/min) was calculated
as (140 ⫺ age) ⫻ (weight in kg)/serum creatinine (mg/dl) ⫻ 72 ⫻ (0.85 if
female) (16). The estimated values of Ccr were adjusted to BSA of 1.73 m2.
Estimated GFR using the MDRD Study equation (ml/min per 1.73
m2) was calculated as 186 ⫻ [serum creatinine (mg/dl)]⫺1.154 ⫻
(age)⫺0.203 ⫻ (0.742 if female) (13,17). The MDRD Study equation provides an estimate of GFR adjusted to BSA of 1.73 m2; further computation is not required. Reduced GFR was defined as measured Ccr of
⬍60 ml/min per 1.73 m2.

Statistical Analyses
SPSS and Medcalc were used for all analyses (18,19). The prevalence
(95% confidence interval [CI]) of reduced GFR was determined for the
screened population. Estimated creatinine excretion was compared
with age- and gender-matched expected values using the formulas
derived by Walser using two-tailed t test (20). The association between
measured Ccr and estimated GFR on the basis of the CG and MDRD
Study GFR equations was assessed by ordinary linear regression and
Passing and Bablok regression analyses. Comparisons between CG Ccr
and MDRD Study estimated GFR and measured Ccr were assessed by

Variable Definitions
Measured urine creatinine excretion (mg/kg per d) was computed on
the basis of 24-h urine collection urine creatinine (mg/dl) times urine
volume (dl/d) divided by body weight (kg). Observed urine creatinine
excretion (mg/kg per d) was computed as 28.2 ⫺ [0.172 ⫻ age (years)]
for men and 21.9 ⫺ [0.115 ⫻ age (years)] for women (16).
Measured Ccr (ml/min per 1.73 m2) was calculated as creatinine
excretion (mg/kg per d) divided by serum creatinine (mg/dl) divided
by 14.4 (min/d per dl/ml). Values were adjusted to standard body
surface area (BSA) of 1.73 m2 by multiplying by BSA/1.73. BSA was

Figure 1. Distribution of urine creatinine excretion.
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measuring (1) bias (mean estimated versus measured value), (2) precision (coefficient of determination of log-estimated versus log-measured
value), and (3) accuracy (proportion of estimates within 20, 30, and 50%
of measured values). Sensitivity and specificity of serum creatinine and
estimated GFR from CG and MDRD Study equations were expressed
by ROC curves for the diagnosis of reduced GFR (21).

Results
A total of 332 individuals who were aged 40 yr or older were
invited to enroll in the study. All individuals belonged to
Pashtun ethnic subgroup (4). Twenty-four-hour urine samples
were provided by 295 individuals (161 men and 134 women).
The 24-h mean (95% CI) urine volume was 1.3 L/d (1.2 to 1.4
L/d). The 24-h mean urine creatinine excretion (95% CI) was
16.1 (15.2 to 17.1) mg/kg per d in men and 13.1 (12.2 to 14.1)
mg/kg per d in women (Figure 1). Samples with low levels of
urine creatinine (gender-specific level of 10th percentile or less
[9 mg/kg for men and 7 mg/kg for women]) were excluded
from the analysis because of suspicion of undercollection. Thus,
the final sample size was 262 individuals.
The sociodemographic and clinical characteristics of individuals who were included in the final analysis are shown in Table
1. The overall prevalence (95% CI) of reduced GFR was 29.9%
(24.2 to 35.1%): 26.7% (20.1 to 34.6%) in men and 32.5% (24.8 to
41.3%) in women.
Creatinine excretion is shown in Figure 1. Mean observed
creatinine excretion in men and women was 17.5 and 14.1
mg/kg per d in men and women, respectively, compared with
mean expected values of 19.0 and 16.3 mg/kg per d, respectively (P ⬍ 0.002 and P ⬍ 0.001, respectively). Mean (95% CI)
difference between observed and expected creatinine excretion
was 1.5 (0.5 to 2.5) in men and 2.1 (1.2 to 3.0) in women.
The bias in overestimating GFR by the CG and MDRD Study
equations compared with measured Ccr was 6.1 and 8.2

ml/min per 1.73 m2, respectively. Although there seemed to be
relatively more overestimation of Ccr by MDRD Study GFR at
lower levels of Ccr, the test for nonlinearity on using Passing
and Bablok regression analysis was NS (P ⬎ 0.1), indicating no
significant variation at lower versus higher levels of Ccr. The
coefficient of determination for measured Ccr on the logarithmic scale was 66.7 and 55.6% for the CG and MDRD Study
equations, respectively. The proportion of estimates within 20,
30, and 50% of measured Ccr values was 47.7 versus 32.8 (P ⬍
0.001), 64.9 versus 49.6 (P ⬍ 0.001), and 79.4 versus 72.9 (P ⫽
0.07) for CG versus MDRD Study equations, respectively.
The ROC curves in Figure 2 and Tables 2, 3, and 4 illustrate
the sensitivity and the specificity of serum creatinine for the
diagnosis of decreased GFR. Pair-wise comparison of areas
under the ROC curves showed that CG equation was superior
to serum creatinine (P ⫽ 0.004) in men but not in women (P ⫽
0.06). However, differences between ROC curves for MDRD
Study GFR compared with serum creatinine was NS in men
(P ⫽ 0.21) or women (P ⫽ 0.54).

Discussion
This is the first report on the prevalence of reduced GFR in a
population-based sample from South Asia. We found that the
prevalence of reduced GFR was estimated as 29.9% (24.2 to
35.1%) in individuals who were aged 40 yr or older. In addition,
we found lower age- and gender-matched mean values of
creatinine excretion, compared with a predominantly white
population. Furthermore, validation of GFR estimation equations against measured Ccr and cutoff values of serum creatinine and GFR estimates using the CG and MDRD Study equations for detecting reduced GFR are being reported for the first
time in a South Asian population. Although the agreement
among values of CG Ccr and MDRD Study GFR prediction

Table 1. Differences in characteristics between individuals with and without reduced GFRa
Variables

All

Reduced GFR

No Reduced GFR

P Valueb

No. of subjects
Age, yr (SD)
Men
Low socioeconomic statusc
Illiterate
Tobacco used
Weight, kg (SD)
Body mass index (SD)
Hypertensione
Mean systolic BP (SD)
Mean siastolic BP (SD)
Diabetesf

262
51.4 (9.9)
142 (54.2%)
142 (54.2)
199 (76.0%)
106 (40.4%)
64.7 (13.4)
24.9 (5.1)
128 (48.9%)
139.4 (25.5)
88.6 (13.7)
28 (10.7%)

77
54.8 (12.1)
38 (49.3%)
45 (58.4)
62 (80.5%)
30 (39.0%)
58.1 (11.4)
23.4 (4.7)
42 (54.5%)
146.3 (29.3)
89.5 (15.3)
14 (18.2%)

185
50.1 (8.5)
104 (56.2%)
97 (52.4)
137 (74.1%)
76 (41.1%)
67.5 (13.3)
25.4 (5.1)
86 (46.5%)
136.4 (23.0)
88.2 (13.0)
14 (7.8%)

⬍0.001
0.30
0.37
0.26
0.75
⬍0.001
0.002
0.23
0.01
0.07
0.01

Reduced GFR defined as measured creatinine clearance ⬍60 ml/min per 1.73 m2.
P values are for differences in characteristics between subjects with and without reduced GFR.
c
Defined as the total monthly household income of ⬍10,000 rupees (60 rupees ⫽ $1 US).
d
Defined as current use of inhaled or chewable tobacco.
e
Defined as mean systolic BP ⱖ140 mmHg or mean diastolic BP ⱖ90 mmHg on two separate occasions or taking
antihypertensive medications.
f
Defined as patients taking antidiabetes medications or having fasting blood sugar ⬎126 mg/dl.
a

b
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Figure 2. Comparison of area under the receiver operating
characteristic (ROC) curve among SCr, Modification of Diet in
Renal Disease (MDRD) study GFR, and Cockcroft Gault (CG)
creatinine clearance (Ccr) equations for reduced GFR. (A) ROC
curve for sensitivity and specificity of levels of SCr for reduced
GFR in men (reduced GFR defined as measured Ccr ⬍60
ml/min per 1.73 m2). (B) ROC curve for sensitivity and specificity of levels of SCr for reduced GFR in women (reduced GFR
defined as measured Ccr ⬍60 ml/min per 1.73 m2).

equations with measured Ccr was not as good as reported in
other populations, both equations performed better than serum
creatinine.
Although being reported for the first time, the alarmingly
high prevalence of reduced GFR in adult men and women in
Pakistan is not unexpected as the prevalence of risk factors of
CKD including hypertension and diabetes is one of the highest
reported worldwide (22). The National Health Survey of Pakistan (1990 to 1994) showed that one of three individuals aged 45
yr or older has hypertension. The prevalence of diabetes in
South Asian countries is two- to three-fold higher than that
reported for Western countries (5). The high prevalence of other
chronic diseases in this population suggests that the burden of
CKD is likely to be high. Unless prompt attention is given to
prevention of chronic diseases, the rising burden of these dangerous conditions would reflect in an even higher burden of
CKD in this vulnerable population.

J Am Soc Nephrol 16: 1413–1419, 2005

Undercollection of 24-h urine samples can lead to underestimation of measured Ccr, thus overestimating the prevalence of
reduced GFR. The mean urine creatinine excretion rate in our
study were generally lower (mean [95% CI] levels, 16.1 mg/kg
[15.2 to 17.1] mg/kg per d in men and 13.1 [12.2 to 14.1] mg/kg
per d in women; Figure 1) compared with the estimated levels
for age- and gender-matched white individuals. This suggests
that undercollection of urine samples could be a potential
source of bias in our study. For a number of reasons, we believe
that this is not the likely explanation. In our study, trained
community research workers emphasized adequacy of urine
collection to the participants and advised appropriate recollection in cases of doubt. Furthermore, we deleted samples that
contained values of 24-h urine creatinine excretion at the 10th
percentile or less of the distribution of urine creatinine levels in
the study population. The distribution of urine volume did not
seem to vary significantly across lower and higher values of
measured Ccr (data not shown). Moreover, the relationship
between predicted GFR and measured Ccr did not seem to vary
significantly according to the level of measured Ccr.
Creatinine is produced nonenzymatically in skeletal muscle,
and the amount of creatinine production and, therefore, 24-h
excretion of creatinine, are directly related to muscle mass (23).
Furthermore, dietary meat intake has been shown to influence
serum creatinine levels (24,25). It is likely that the lower creatinine excretion observed in our study reflects differences in
muscle mass and dietary meat intake. Asians generally have
lower muscle mass for body weight than whites and lower
meat intake (26 –28). Population-based studies would be necessary to determine true age- and gender-specific values for
creatinine excretion in South Asia. A number of GFR estimating
equations have been developed to overcome some of the limitations of estimating GFR from serum creatinine. The CG equation was developed in 1973 and is used widely. A newer
equation, the MDRD Study equation, was developed in 1999
and since then has been validated in a number of populations,
has been rigorously developed and validated, and is now recommended by the National Institute of Diabetes and Digestive
and Kidney Diseases, the National Kidney Foundation (NKF),
and American Society of Nephrology for use in clinical practice
(13,17). However, neither of these equations was developed or
validated in the South Asian population. Although neither of
these equations performed as well in our study population,
both were superior to serum creatinine level alone for diagnosis
of reduced GFR.
Early detection and treatment of CKD can prevent some of its
complications (6 –10). This is especially pertinent to developing
countries, where support for kidney replacement therapy is
lacking for the vast majority of patients with advanced kidney
disease (29). Elevated levels of serum creatinine mark the presence of reduction in GFR. Serum creatinine levels ⬎1.2 mg/dl
in women and 1.6 mg/dl in men have been found to be approximately 90% sensitive for detecting GFR of ⬍60 ml/min
per 1.73 m2 (30). Even higher threshold levels are recommended for screening for reduced GFR in the NKF-sponsored
Kidney Early Evaluation Program (31). However, these cutoff
levels are based on data from a white population (30). Our data
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Table 2. Area under ROC curve (95% CI) and suggested cutoff values for diagnosis of reduced GFRa

Area under curve
serum creatinine
MDRD Study GFR
CG Ccr
Cutoffs: sensitivity and specificity
serum creatinine (mg/dl)
MDRD Study GFR (ml/min)
CG Ccr (ml/min per 1.73 m2)

Men

Women

0.79 (0.71 to 0.85)
0.88 (0.82 to 0.93)
0.90 (0.84 to 0.94)

0.83 (0.75 to 0.89)
0.88 (0.80 to 0.93)
0.89 (0.82 to 0.94)

⬍0.9: 74 and 68%
⬍78: 68 and 85%
⬍72: 84 and 84%

0.7: 82 and 73%
⬍86: 85 and 73%
⬍82: 85 and 78%

a
ROC, receiver operating characteristic; CI, confidence interval; MDRD, Modification of Diet in Renal Disease; CG,
Cockcroft-Gault; Ccr, creatinine clearance.

Table 3. ROC curve for sensitivity and specificity of levels of serum creatinine for reduced GFR in womena
SCr (mg/dl)

⬎0.27
⬎0.36
⬎0.45
⬎0.55
⬎0.64
⬎0.73a
⬎0.82
⬎0.9
⬎0.91
⬎1
⬎1.09
⬎1.18
⬎1.27
⬎1.55
⬎1.73

Sensitivity (95% CI)

100.0
100.0
100.0
94.9
87.2
82.1
56.4
56.4
35.9
30.8
23.1
15.4
10.3
7.7
5.1

(90.9 to 100.0)
(90.9 to 100.0)
(90.9 to 100.0)
(82.6 to 99.2)
(72.6 to 95.7)
(66.5 to 92.4)
(39.6 to 72.2)
(39.6 to 72.2)
(21.2 to 52.8)
(17.0 to 47.6)
(11.2 to 39.3)
(5.9 to 30.5)
(2.9 to 24.2)
(1.7 to 20.9)
(0.8 to 17.4)

Specificity (95% CI)

2.5
9.9
22.2
35.8
55.6
72.8
85.2
86.4
93.8
98.8
100.0
100.0
100.0
100.0
100.0

(0.4 to 8.7)
(4.4 to 18.5)
(13.7 to 32.8)
(25.5 to 47.2)
(44.1 to 66.6)
(61.8 to 82.1)
(75.5 to 92.1)
(77.0 to 93.0)
(86.2 to 97.9)
(93.3 to 99.8)
(95.5 to 100.0)
(95.5 to 100.0)
(95.5 to 100.0)
(95.5 to 100.0)
(95.5 to 100.0)

⫹LR

⫺LR

1.03
1.11
1.29
1.48
1.96
3.02
3.81
4.15
5.82
24.92

0.00
0.00
0.00
0.14
0.23
0.25
0.51
0.50
0.68
0.70
0.77
0.85
0.90
0.92
0.95

Reduced GFR defined as measured Ccr ⬍ 60 ml/min per 1.73 m2. Corresponding values of Scr (mg/dl) in women are
listed along the ROC curve.
Area under the ROC curve ⫽ 0.827. 95% CI ⫽ 0.747 to 0.890.
a

suggest that the levels of serum creatinine indicating reduced
GFR in South Asian population are lower. Cutoff values of
serum creatinine of 0.91 mg/dl yielded sensitivity and specificity of 74 and 68% for the presence of reduced GFR in men,
and a value of 0.73 mg/dl yielded 82 and 73% of the same in
women, respectively. Even lower cutoff values of serum creatinine were associated with higher sensitivity. Therefore, using
cutoff values for serum creatinine as suggested for primarily
white populations would fail to detect approximately 80% of
patients of South Asian origin with early-reduced GFR. This
difference is probably due to lower creatinine excretion. Data
from the West suggest that a greater proportion of South Asians
than native whites develop kidney failure (3). It is possible that
this is due in part to late detection of CKD based on a level of
serum creatinine that may be too high for this population. Our
findings emphasize the importance of using a lower threshold
level of serum creatinine.
Our findings suggest that it would be even better to use GFR

estimating equations for evaluation of reduced GFR in South
Asians. We recommend that laboratories report values of estimated GFR in addition to serum creatinine levels. Levels of
estimated GFR ⬍70 and 80 ml/min per 1.73 m2 in men and
women, respectively, should prompt further evaluation and
management as per the NKF Kidney Disease Outcomes Quality
Initiative action plan for CKD (32).
Our analyses have limitations. First, the gold standard for
diagnosis of reduced GFR was based on measured Ccr and not
measured GFR. However, Ccr tends to overestimate GFR, especially in patients with reduced GFR (13). Therefore, the true
prevalence of reduced GFR is likely to be been greater. However, undercollection of 24-h urine samples can lead to underestimation of measured Ccr and, thus, overestimation of reduced GFR. As discussed, although we cannot exclude the
possibility that undercollection of urine samples contributed to
the high prevalence of decreased GFR observed in our study,
we believe that it is unlikely to be a major source of bias.
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Table 4. ROC curve for sensitivity and specificity of levels of serum creatinine for reduced GFR in mena
SCr (mg/dl)

⬎0.36
⬎0.45
⬎0.55
⬎0.57
⬎0.64
⬎0.73
⬎0.82
⬎0.9
⬎0.91
⬎1a
⬎1.09
⬎1.1
⬎1.18
⬎1.27
⬎1.36
⬎1.45
⬎1.55
⬎1.64
⬎1.73

Sensitivity (95% CI)

100.0
100.0
100.0
100.0
100.0
94.7
81.6
81.6
73.7
65.8
50.0
47.4
36.8
28.9
23.7
21.1
18.4
15.8
15.8

(90.7 to 100.0)
(90.7 to 100.0)
(90.7 to 100.0)
(90.7 to 100.0)
(90.7 to 100.0)
(82.2 to 99.2)
(65.7 to 92.2)
(65.7 to 92.2)
(56.9 to 86.6)
(48.6 to 80.4)
(33.4 to 66.6)
(31.0 to 64.2)
(21.8 to 54.0)
(15.4 to 45.9)
(11.5 to 40.2)
(9.6 to 37.3)
(7.8 to 34.3)
(6.1 to 31.3)
(6.1 to 31.3)

Specificity (95% CI)

1.9
4.8
13.5
14.4
24.0
32.7
46.2
47.1
68.3
83.7
87.5
87.5
91.3
96.2
99.0
99.0
99.0
99.0
100.0

(0.3 to 6.8)
(1.6 to 10.9)
(7.6 to 21.6)
(8.3 to 22.7)
(16.2 to 33.4)
(23.8 to 42.6)
(36.3 to 56.2)
(37.2 to 57.1)
(58.4 to 77.0)
(75.1 to 90.2)
(79.6 to 93.2)
(79.6 to 93.2)
(84.2 to 96.0)
(90.4 to 98.9)
(94.7 to 99.8)
(94.7 to 99.8)
(94.7 to 99.8)
(94.7 to 99.8)
(96.5 to 100.0)

⫹LR

⫺LR

1.02
1.05
1.16
1.17
1.32
1.41
1.52
1.54
2.32
4.02
4.00
3.79
4.26
7.53
24.63
21.89
19.16
16.42

0.00
0.00
0.00
0.00
0.00
0.16
0.40
0.39
0.39
0.41
0.57
0.60
0.69
0.74
0.77
0.80
0.82
0.85
0.84

a
Reduced GFR defined as measured Ccr ⬍ 60ml/min per 1.73 m2. Corresponding values of serum creatinine (mg/dl) in
men are listed along the ROC curve.
Scr, Serum creatinine; ⫹LR, positive likelihood ratio; ⫺LR, negative likelihood ratio.
Area under the ROC curve ⫽ 0.786. 95% CI ⫽ 0.709 to 0.850.

Second, diagnosis of CKD requires persistent reduction in GFR
for at least 3 mo (12). The estimates of reduced GFR in our
study are based on a single measurement of Ccr. Nevertheless,
single measurements of serum creatinine are considered appropriate for epidemiologic and screening purposes (31). Third,
GFR estimation equations have been developed to estimate
GFR against the gold standard of measured GFR and have been
shown to underestimate measured Ccr by approximately 15%
(13). This may explain the poorer performance of the MDRD
Study compared with the CG equation, which was developed
to estimate Ccr. Moreover, the assay for serum creatinine in our
study has not been calibrated to the laboratories used for developing these equations. Despite these limitations, both CG
and MDRD Study equations performed better than serum creatinine alone (Figure 2). Nonetheless, GFR estimating equations
could likely be improved by including terms for populations
that have lower muscle mass and meat intake. Finally, all
individuals in our study belonged to the Pashtun ethnic subgroup, which has been reported to have relatively higher body
mass index than some of the other South Asian ethnic subgroups; GFR estimation equations need validation in the latter
subgroups (4).
In conclusion, there is a high prevalence of reduced GFR in
the adult population of urban Pakistan. GFR estimates using
serum creatinine and the CG or MDRD Study equations are
better predictors of reduced GFR than serum creatinine alone.
Our findings underscore the importance or reporting estimated
GFR using current equations and of further improving GFR
estimating equations in the South Asian population.

References
1. Chandie Shaw PK, Vandenbroucke JP, Tjandra YI, Rosendaal FR, Rosman JB, Geerlings W, de Charro FT, van Es
LA: Increased end-stage diabetic nephropathy in IndoAsian immigrants living in the Netherlands. Diabetologia
45: 337–341, 2002
2. Fischbacher CM, Bhopal R, Rutter MK, Unwin NC, Marshall SM, White M, Alberti KG: Microalbuminuria is more
frequent in South Asian than in European origin populations: A comparative study in Newcastle, UK. Diabet Med
20: 31–36, 2003
3. Trehan A, Winterbottom J, Lane B, Foley R, Venning M, Coward
R, MacLeod AM, Gokal R: End-stage renal disease in IndoAsians in the North-West of England. QJM 96: 499–504, 2003
4. Jafar TH, Levey AS, Jafary FH, White F, Gul A, Rahbar
MH, Khan AQ, Hattersley A, Schmid CH, Chaturvedi N:
Ethnic subgroup differences in hypertension in Pakistan.
J Hypertens 21: 905–912, 2003
5. Shera AS, Rafique G, Khwaja IA, Ara J, Baqai S, King H:
Pakistan national diabetes survey: Prevalence of glucose
intolerance and associated factors in Shikarpur, Sindh
Province. Diabet Med 12: 1116 –1121, 1995
6. Locatelli F, Vecchio LD, Pozzoni P: The importance of early
detection of chronic kidney disease. Nephrol Dial Transplant
17[Suppl 11]: 2–7, 2002
7. Foley RN: Anaemia: Cardiovascular adaptations and maladaptive responses in chronic kidney disease. Nephrol Dial
Transplant 17[Suppl 11]: 32–34, 2002
8. Drey N, Roderick P, Mullee M, Rogerson M: A populationbased study of the incidence and outcomes of diagnosed
chronic kidney disease. Am J Kidney Dis 42: 677– 684, 2003

J Am Soc Nephrol 16: 1413–1419, 2005

Serum Creatinine as Marker of Kidney Function in South Asians

9. Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi
G, Maschio G, Brenner BM, Kamper A, Zucchelli P, Becker
G, Himmelmann A, Bannister K, Landais P, Shahinfar S, de
Jong PE, de Zeeuw D, Lau J, Levey AS: Angiotensinconverting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.
Ann Intern Med 135: 73– 87, 2001
10. Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de
Jong PE, de Zeeuw D, Shahinfar S, Toto R, Levey AS:
Progression of chronic kidney disease: The role of blood
pressure control, proteinuria, and angiotensin-converting
enzyme inhibition: A patient-level meta-analysis. Ann Intern Med 139: 244 –252, 2003
11. Smith H: Comparative physiology of the kidney. In: The Kidney:
Structure and Function in Heath and Disease, edited by Smith H,
Oxford University Press, New York, 1951, pp 520–524
12. Levey AS: Clinical practice. Nondiabetic kidney disease.
N Engl J Med 347: 1505–1511, 2002
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D:
A more accurate method to estimate glomerular filtration
rate from serum creatinine: A new prediction equation.
Modification of Diet in Renal Disease Study Group. Ann
Intern Med 130: 461– 470, 1999
14. Donahue A, McCune JS, Faucette S, Gillenwater HH, Kowalski RJ, Socinski MA, Lindley C: Measured versus estimated glomerular filtration rate in the Calvert equation:
Influence on carboplatin dosing. Cancer Chemother Pharmacol 47: 373–379, 2001
15. Caravaca F, Arrobas M, Luna E, Naranjo M, Pizarro JL,
Sanchez-Casado E: [Differences between the glomerular
filtration rate estimated by the MDRD equation and the
measurement of creatinine and urea clearance in unselected patients with terminal renal insufficiency]. Nefrologia 22: 432– 437, 2002
16. Cockroft D, Gault M: Prediction of creatinine clearance
from serum creatinine. Nephron 16: 31– 41, 1976
17. Levey A, Greene T, Kusek J, Beck G: A simplified equation
to predict glomerular filtration rate from serum creatinine
[Abstract]. J Am Soc Nephrol 11: 155A, 2000
18. Horstmann GA, Dietz V: The contribution of vestibular
input to the stabilization of human posture: A new experimental approach. Neurosci Lett 95: 179 –184, 1988
19. Schoonjans F, Zalata A, Depuydt CE, Comhaire FH: MedCalc: A new computer program for medical statistics. Comput Methods Programs Biomed 48: 257–262, 1995
20. Walser M: Creatinine excretion as a measure of protein

21.
22.

23.

24.

25.

26.
27.

28.

29.

30.

31.

32.

1419

nutrition in adults of varying age. JPEN J Parenter Enteral
Nutr 11: 73S–78S, 1987
Faraggi D, Reiser B: Estimation of the area under the ROC
curve. Stat Med 21: 3093–3106, 2002
Jafar TH, Chaturvedi N, Gul A, Khan AQ, Schmid CH,
Levey AS: Ethnic differences and determinants of proteinuria among South Asian subgroups in Pakistan. Kidney Int
64: 1437–1444, 2003
Swaminathan R, Major P, Snieder H, Spector T: Serum
creatinine and fat-free mass (lean body mass). Clin Chem
46: 1695–1696, 2000
Jacobsen FK, Christensen CK, Mogensen CE, Andreasen F,
Heilskov NS: Pronounced increase in serum creatinine
concentration after eating cooked meat. BMJ 1: 1049 –1050,
1979
Mayersohn M, Conrad KA, Achari R: The influence of a
cooked meat meal on creatinine plasma concentration and
creatinine clearance. Br J Clin Pharmacol 15: 227–230, 1983
Choo V: WHO reassesses appropriate body-mass index for
Asian populations. Lancet 360: 235, 2002
D’Souza SW, Lakhani P, Waters HM, Boardman KM,
Cinkotai KI: Iron deficiency in ethnic minorities: Associations with dietary fibre and phytate. Early Hum Dev 15:
103–111, 1987
Lee RC, Wang Z, Heo M, Ross R, Janssen I, Heymsfield SB:
Total-body skeletal muscle mass: Development and crossvalidation of anthropometric prediction models. Am J Clin
Nutr 72: 796 – 803, 2000
Sakhuja V, Sud K: End-stage renal disease in India and
Pakistan: Burden of disease and management issues. Kidney Int Suppl S115–S118, 2003
Couchoud C, Pozet N, Labeeuw M, Pouteil-Noble C:
Screening early renal failure: Cut-off values for serum creatinine as an indicator of renal impairment. Kidney Int 55:
1878 –1884, 1999
Brown WW, Peters RM, Ohmit SE, Keane WF, Collins A,
Chen SC, King K, Klag MJ, Molony DA, Flack JM: Early
detection of kidney disease in community settings: The
Kidney Early Evaluation Program (KEEP). Am J Kidney Dis
42: 22–35, 2003
Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes
MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National
Kidney Foundation practice guidelines for chronic kidney
disease: Evaluation, classification, and stratification. Ann
Intern Med 139: 137–147, 2003

